Abstract. Since 2013 physics of TPU and oncologists from the TCRI with participation of the "ConMet" company (Moscow) and the "Sintel" company (Tomsk Special Economic Zone resident) have been working on the theme entitled
INTRODUCTION
The objective of this work was to carry out preliminary market research of the titanium implants with multifunctional bioactive coatings by means of comparing them with existing oncology-surgical demands. There are plenty of types of foreign implants [2] . Unfortunately, Russian implants used in federal hospitals are not usually coated, and their frequency of rejection is about 10-30%. According to A.I. Karpov & A. A. Bolotov from the Chelyabinsk State Medical Academy [3] , the mean area of the bone defects of the head after a radical surgical treatment amounts up to 151.7 cm 2 . Sometimes the combined defects of a cranio-maxillo-facial (Cranio Maxillofacial Fixation or CMF) area are not compatible with a normal life of a patient, and the simultaneous plastic surgery can just save his life. So, good composite implants are an important part for decreasing the losses of the Russian population from the oncology diseases.
The prototype of our plate coated with biodegradable materials for the reconstructive craniomaxillofacial surgery was developed by the physicists of TPU and the oncologists from the TCRI with participation of the "ConMet" company (Moscow) and the "Sintel" company (Tomsk Special Economic Zone resident).
METHODOLOGY
The stages of the preliminary market research were: 1) a survey of the Worldwide CMF market, 2) forecasting the BRIC CMF market up to 2020, 3) estimation of the total Russian market (epidemiology) as sum of official calculations and statistics, 4) looking for the best foreign analogue prices, comparison of their and our implant properties, 5) a searching for the best Russian analogues, and matching them too, 6) the mining the world patent database of the last years, and finding the owners and applicants of patents of CMF osteosynthesis plates on a basis of a titanium coated with PLA& hydroxyapatite, 7) comparison of the domestic implants, and finally, making conclusions. 
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Trends of the Worldwide CMF Market Up To 2020
The Worlwide CMF market costs $5.2 billions, CAGR > 6%. Worldwide leader of 2009 was SYNTHES (43%). Other key players of the market were Smith&Nephew, Zimmer, DePuy, Biomet, Acumed and Orthofix, and sales of each company are more than $100 million yearly. BRIC ratio is shown in Fig. 2 . 
Russian Market and Epidemiology Estimations
According to 1200 top-managers of organizations-suppliers, which are the manufacturers and buyers of orthopedic products from 15 countries, the Russian CMF market costs about dozen millions dollars of USA (according to 2016 prices). The size of the Russian market of implants can be defined of about 50 thousand units with an average price of 15-20 thousands RUB per unit (there are no official statistics).
The adult tumors of head and neck are about 20-30% of total sum. There are 50 thousands of new patients of this etiology in Russia per year [5] . The annual growth is about 2%. There are observed 17.5 thousands/year malignant neoplasms among Russian children. Unfortunately, 10% of all tumors malignant are maxillofacial ones among children. The need of the Russian Federation in customized CMF is about 50 thousand units/year. The frequency of rejections is from 5 up to 30% for both foreign and Russian implants.
Comparison of Foreign and Our Implants Properties and Prices
We found the best CMF analogue prices [2] , which are given in Table 1 . Our plate has over 2-8-times difference in comparison with analogues prices, and the same quality, and it's a very important news for Russian hospitals due to the Euro and USD/RUB ratio rising.
The Investigation of the Espacenet Data for the Last Years
According to the Espacenet Patent Base (2010-2015), the most active companies with more than two patents of the plates for the cranio-maxillo-facial osteosynthesis or fixation on the basis of titanium alloys coated with apatite are shown in Fig. 3 . The query of Espacenet was "titan AND plate AND apatite AND maxillo OR facial OR cranial in the title or abstract AND 2010-2015 as the publication date AND A61B17 as the IPC classification".
The Synthes company and the Shanghai American School of Medicine were 5-year-leaders in such patenting. Unfortunately, the Russian patent owners have not claimed the similar domestic CMF-plates. 
Comparison of the Implants
Comparison of the properties of our implants with the best materials-competitors of the Russian and foreign companies is given in Table 2 .
It may be concluded that our implant is equal with the best Russian and foreign implants. Our concurrent properties are intraoperative shaping of the implant, accelerated osseointegration, and cost.
CONCLUSIONS
So, the prototype of our plate coated with biodegradable materials for the substitution of bone defects was developed by the physicists of TPU and the oncologists from the TCRI with a participation of the "ConMet" company (Moscow) and the "Sintel" company (Tomsk Special Economic Zone resident) for their applicability for the reconstructive cranio-maxillofacial surgery. The team of developers have to begin supply of these advanced implants to the industrial partners up to 2017. That is the reason why pre-marketing research is so urgent now.
We found that there is not any producer of the coated CMF-implants into Russia. It may be concluded that the quality of our implant is equal with the best Russian and foreign implants. But the average price of the similar foreign implants varies from 12 to 40 USD per 1 cm 2 . Our prototype costs less than 12 USD per 1 cm 2 . Worldwide leader of 2009 was SYNTHES (43%). Also the Synthes company and the Shanghai American School of Medicine for 5 years were the leaders in the patenting of CMF. So, SYNTHES is the most active and competitive company. Our concurrent properties of the plate vs. the Synthes implants are the intraoperative shaping of the implant, accelerated osseointegration, oncological safety and cost.
The price of the one mesh plate of 60×50×1 mm 3 on the Russian market may not exceed the price 7-10 USD per 1 cm 2 . Russian hospitals have the limited budget for each kind of the high technological operations with an implant application due to the medicine quota system. That is why it is the good news for Russian doctors.
It is well known that the additional layers of PLA and HAP are very good for patients. The only hybrid titanium "Grey" implant with layers of gelatin, dextran, collagen, HAP & BMP-2 was found. This implant was introduced by Russian institution, and it was mentioned in the report on clinical trials by L.A. Pavlova et al., 2014 [1] . Nowadays these implants are not produced in Russia. We need to follow this research group to know their progress.
At the present time among the most promising bioresorbable materials for implants it is possible to choose the lactic acid and the hydroxyapatite [6] . They are used to restore the defects of bone and cartilage in clinical practice, and they were approved of by the FDA (Food and Drug Administration).
The new trend is creation of the pre-modeled products of the premium quality for the personal application. There are a few Russian oncologists interviewed, and they consider that our prototype needs a combination of the best functionality, the average price, the good personification of implants, and the preparation "by order" [7, 8] .
Thus, our preliminary market research gave us and the producer very valuable information for the future R&D.
